Carlyle ends boardroom spat at India's Metropolis

The US private equity firm's purchase of a stake in the pathology laboratories chain signals an end to a boardroom battle triggered by Warburg Pincus' exit earlier this year.

Carlyle ends boardroom spat at India's Metropolis

The Carlyle Group said on Wednesday it had acquired a stake in Metropolis Healthcare, a chain of pathology laboratories in India, signaling an end to a boardroom battle between the founders. 

Rival private equity firm Warburg Pincus sold its 27% stake in Metropolis in April to the Shah family which triggered a change of control and the end of a long-running power struggle between the founders, Sushil Shah and GSK Velu. 

...

To continue reading, please login or register for free

Click for more on: carlyle | health | private equity | india | acquisitions

Print Edition

FinanceAsia Print Edition

CONFERENCES